Targeting brain angiotensin and corticotrophin-releasing hormone systems interaction for the treatment of mood and alcohol use disorders

Journal of Molecular Medicine

Volumn 86, Issue 6, 2008, Pages 723-728

  Sommer, Wolfgang H ^a   Saavedra, Juan M ^b  

^a NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM   (United States)

^b NATIONAL INSTITUTE OF MENTAL HEALTH   (United States)

Author keywords

ACE; Alcoholism; Angiotensin receptor; Anxiety; Gene expression

Indexed keywords

ANGIOTENSIN; CORTICOTROPIN; CORTICOTROPIN RELEASING FACTOR;

ADDICTION; ALCOHOL CONSUMPTION; ALCOHOLISM; ALLOSTASIS; ANXIETY DISORDER; NEUROCHEMISTRY; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; REVIEW;

ALCOHOL-RELATED DISORDERS; ALLOSTASIS; ANGIOTENSINS; ANIMALS; BRAIN; CORTICOTROPIN-RELEASING HORMONE; HUMANS; MOOD DISORDERS;

EID: 43449118047     PISSN: 09462716     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00109-008-0333-3     Document Type: Review

References (35)

1. Saavedra JM (2005) Brain angiotensin II: new developments, unanswered questions and therapeutic opportunities. Cell Mol Neurobiol 25:485-512
2. Saavedra JM, Benicky J (2007) Brain and peripheral angiotensin II play a major role in stress. Stress 10:185-193
3. Esler M (2002) Differentiation in the effects of the angiotensin II receptor blocker class on autonomic function. J Hypertens Suppl 20:S13-S19
4. McEwen BS (2007) Physiology and neurobiology of stress and adaptation: central role of the brain. Physiol Rev 87:873-904
5. Heinrichs SC, Koob GF (2004) Corticotropin-releasing factor in brain: a role in activation, arousal, and affect regulation. J Pharmacol Exp Ther 311:427-440
6. Sommer WH, Rimondini R, Hansson AC, Hipskind PA, Gehlert DR, Barr CS, Heilig M (2008) Upregulation of voluntary alcohol intake, behavioral sensitivity to stress, and amygdala Crhr1 expression following a history of dependence. Biol Psychiatry 63:139-145
7. Saavedra JM, Armando I, Bregonzio C, Juorio A, Macova M, Pavel J, Sanchez-Lemus E (2006) A centrally acting, anxiolytic angiotensin II AT1 receptor antagonist prevents the isolation stress-induced decrease in cortical CRF1 receptor and benzodiazepine binding. Neuropsychopharmacology 31:1123-1134
8. Bregonzio C, Seltzer A, Armando I, Pavel J, Saavedra J M (2008) Angiotensin II AT1 receptor blockade selectively enhances brain AT2 receptor expression, and abolishes the cold-restraint stress-induced increase in tyrosine hydroxylase mRNA in the locus coeruleus of spontaneously hypertensive rats. Stress (in press)
9. Armando I, Volpi S, Aguilera G, Saavedra JM (2007) Angiotensin II AT1 receptor blockade prevents the hypothalamic corticotropin-releasing factor response to isolation stress. Brain Res 1142:92-99
10. Armando I, Carranza A, Nishimura Y, Hoe KL, Barontini M, Terron JA, Falcon-Neri A, Ito T, Juorio AV, Saavedra JM (2001) Peripheral administration of an angiotensin II AT(1) receptor antagonist decreases the hypothalamic- pituitary-adrenal response to isolation stress. Endocrinology 142:3880-3889
11. Bregonzio C, Armando I, Ando H, Jezova M, Baiardi G, Saavedra JM (2003) Anti-inflammatory effects of angiotensin II AT1 receptor antagonism prevent stress-induced gastric injury. Am J Physiol Gastrointest Liver Physiol 285:G414-G423
12. Fitts DA (1993) Angiotensin and captopril increase alcohol intake. Pharmacol Biochem Behav 45:35-43
13. Grupp LA (1987) Alcohol satiety, hypertension and the renin-angiotensin system. Med Hypotheses 24:11-19
14. Weisinger RS, Blair-West JR, Denton DA, McBurnie MI (1999) Angiotensin II stimulates intake of ethanol in C57BL/6J mice. Physiol Behav 67:369-376
15. Maul B, Siems WE, Hoehe MR, Grecksch G, Bader M, Walther T (2001) Alcohol consumption is controlled by angiotensin II. FASEB J 15:1640-1642
16. Maul B, Krause W, Pankow K, Becker M, Gembardt F, Alenina N, Walther T, Bader M, Siems WE (2005) Central angiotensin II controls alcohol consumption via its AT1 receptor. FASEB J 19:1474-1481
17. Saba L, Bhave SV, Grahame N, Bice P, Lapadat R, Belknap J, Hoffman PL, Tabakoff B (2006) Candidate genes and their regulatory elements: alcohol preference and tolerance. Mamm Genome 17:669-688
18. Rodd ZA, Bertsch BA, Strother WN, Le-Niculescu H, Balaraman Y, Hayden E, Jerome RE, Lumeng L, Nurnberger JI Jr., Edenberg HJ, McBride WJ, Niculescu AB (2006) Candidate genes, pathways and mechanisms for alcoholism: an expanded convergent functional genomics approach. Pharmacogenomics J 6:1-3
19. Sommer W, Hyytia P, Kiianmaa K (2006) The alcohol-preferring AA and alcohol-avoiding ANA rats: neurobiology of the regulation of alcohol drinking. Addict Biol 11:289-309
20. Grupp LA (1992) Effects of angiotensin II and an angiotensin converting enzyme inhibitor on alcohol intake in P and NP rats. Pharmacol Biochem Behav 41:105-108
21. Egli M (2005) Can experimental paradigms and animal models be used to discover clinically effective medications for alcoholism? Addict Biol 10:309-319
22. Rimondini R, Arlinde C, Sommer W, Heilig M (2002) Long-lasting increase in voluntary ethanol consumption and transcriptional regulation in the rat brain after intermittent exposure to alcohol. FASEB J 16:27-35
23. Heilig M, Koob GF (2007) A key role for corticotropin-releasing factor in alcohol dependence. Trends Neurosci 30:399-406
24. Hansson AC, Cippitelli A, Sommer WH, Fedeli A, Bjork K, Soverchia L, Terasmaa A, Massi M, Heilig M, Ciccocioppo R (2006) Variation at the rat Crhr1 locus and sensitivity to relapse into alcohol seeking induced by environmental stress. Proc Natl Acad Sci U S A 103:15236-15241
25. Gehlert DR, Cippitelli A, Thorsell A, Le AD, Hipskind PA, Hamdouchi C, Lu J, Hembre EJ, Cramer J, Song M, McKinzie D, Morin M, Ciccocioppo R, Heilig M (2007) 3-(4-Chloro-2-morpholin-4-yl-thiazol-5-yl)-8-(1-ethylpropyl)-2,6- dimethyl-imidazo[1,2-b]pyridazine: a novel brain-penetrant, orally available corticotropin-releasing factor receptor 1 antagonist with efficacy in animal models of alcoholism. J Neurosci 27:2718-2726
26. Funk CK, O'Dell LE, Crawford EF, Koob GF (2006) Corticotropin-releasing factor within the central nucleus of the amygdala mediates enhanced ethanol self-administration in withdrawn, ethanol-dependent rats. J Neurosci 26:11324-11332
27. Hansson AC, Cippitelli A, Sommer W, Ciccocioppo R, Heilig M (2007) Region-specific down regulation of Crhr1 gene expression in alcohol preferring msP rats following ad lib access to alcohol. Addict Biol 12:30-34
28. Sommer WH, Rimondini R, Marquitz M, Lidström J, Siems WE, Bader M, Heilig M (2007) Plasticity and impact of the central renin-angiotensin system during development of ethanol dependence. J Mol Med 85:1089-1097
29. Schinke M, Baltatu O, Bohm M, Peters J, Rascher W, Bricca G, Lippoldt A, Ganten D, Bader M (1999) Blood pressure reduction and diabetes insipidus in transgenic rats deficient in brain angiotensinogen. Proc Natl Acad Sci U S A 96:3975-3980
30. Steckler T, Dautzenberg FM (2006) Corticotropin-releasing factor receptor antagonists in affective disorders and drug dependence-an update. CNS Neurol Disord Drug Targets 5:147-165
31. Holsboer F (2003) Corticotropin-releasing hormone modulators and depression. Curr Opin Investig Drugs 4:46-50
32. Ising M, Zimmermann US, Kunzel HE, Uhr M, Foster AC, Learned-Coughlin SM, Holsboer F, Grigoriadis DE (2007) High-affinity CRF1 receptor antagonist NBI-34041: preclinical and clinical data suggest safety and efficacy in attenuating elevated stress response. Neuropsychopharmacology 32(9):1941-1949
33. Sterling P, Eyer J (1988) Allostasis: a new paradigm to explain arousal pathology. In: Fisher R, Reason J (eds) Handbook of life stress, cognition and health. Wiley, New York, pp 629-649
34. Koob GF, Le Moal M (2008) Addiction and the brain antireward system. Annu Rev Psychol 59:29-53
35. Sanchis-Segura C, Spanagel R (2006) Behavioural assessment of drug reinforcement and addictive features in rodents: an overview. Addict Biol 11:2-338